Measuring the quality of life in men with prostate cancer.
Men diagnosed with prostate cancer (PCa) choose treatments based on known side effects that impact health-related quality of life (HRQL). This study evaluated the psychometric properties of the UCLA Prostate Cancer Index (UCLA-PCI) and the Short Form Health Survey (SF-12v2).